Circadian Clock and Stress Interactions in the Molecular Biology of Psychiatric Disorders

Current Psychiatry Reports

Volumn 16, Issue 10, 2014, Pages

  Landgraf, Dominic ^a,b   McCarthy, Michael J ^a,b   Welsh, David K ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol use disorder; Attention deficit hyperactivity disorder; Bipolar disorder; Circadian clock; Major depressive disorder; Post traumatic stress disorder; Schizophrenia; Stress

Indexed keywords

EID: 84905871170     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-014-0483-7     Document Type: Review

References (125)

1. Daan S, Pittendrigh CS. A Functional analysis of circadian pacemakers in nocturnal rodents. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 1976;106(3):223–355.
2. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517–49. doi:10.1146/annurev-physiol-021909-135821.
3. Ecker JL, Dumitrescu ON, Wong KY, Alam NM, Chen SK, LeGates T, et al. Melanopsin-expressing retinal ganglion-cell photoreceptors: cellular diversity and role in pattern vision. Neuron. 2010;67(1):49–60. doi:10.1016/j.neuron.2010.05.023.
4. Koike N, Yoo SH, Huang HC, Kumar V, Lee C, Kim TK, et al. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science. 2012;338(6105):349–54. doi:10.1126/science.1226339.
5. Lowrey PL, Takahashi JS. Genetics of circadian rhythms in Mammalian model organisms. Adv Genet. 2011;74:175–230. doi:10.1016/B978-0-12-387690-4.00006-4.
6. Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010;11(8):589–99. doi:10.1038/nrn2868.
7. Rosenberg R, Doghramji PP. Is shift work making your patient sick? Emerging theories and therapies for treating shift work disorder. Postgrad Med. 2011;123(5):106–15. doi:10.3810/pgm.2011.09.2465.
8. Katz G, Durst R, Zislin Y, Barel Y, Knobler HY. Psychiatric aspects of jet lag: review and hypothesis. Med Hypotheses. 2001;56(1):20–3. doi:10.1054/mehy.2000.1094.
9. Landgraf D, McCarthy MJ, Welsh DK. The Role of the Circadian Clock in Animal Models of Mood Disorders. Behav Neurosci. 2014. doi:10.1037/a0036029.
10. Carr CP, Martins CM, Stingel AM, Lemgruber VB, Juruena MF. The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes. J Nerv Ment Dis. 2013;201(12):1007–20. doi:10.1097/NMD.0000000000000049.
11. Ouyang L, Fang X, Mercy J, Perou R, Grosse SD. Attention-deficit/hyperactivity disorder symptoms and child maltreatment: a population-based study. J Pediatr. 2008;153(6):851–6. doi:10.1016/j.jpeds.2008.06.002.
12. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry. 2009;65(1):46–54. doi:10.1016/j.biopsych.2008.10.005.
13. Brietzke E, Kauer Sant'anna M, Jackowski A, Grassi-Oliveira R, Bucker J, Zugman A, et al. Impact of childhood stress on psychopathology. Rev Bras Psiquiatr. 2012;34(4):480–8.
14. de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463–75. doi:10.1038/nrn1683.
15. Lecocq FR, Mebane D, Madison LL. The Acute Effect of Hydrocortisone on Hepatic Glucose Output and Peripheral Glucose Utilization. J Clin Invest. 1964;43:237–46. doi:10.1172/JCI104908.
16. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metab Clin Exp. 2011;60(11):1500–10. doi:10.1016/j.metabol.2011.06.012.
17. Maniam J, Antoniadis C, Morris MJ. Early-Life Stress, HPA Axis Adaptation, and Mechanisms Contributing to Later Health Outcomes. Front Endocrinol. 2014;5:73. doi:10.3389/fendo.2014.00073.
18. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57(10):925–35.
19. Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2–13. doi:10.1016/j.mce.2010.04.005.
20. Carroll BJ. The dexamethasone suppression test for melancholia. Br J Psychiatr J Mental Sci. 1982;140:292–304.
21. Zhang J, Abdallah CG, Chen Y, Huang T, Huang Q, Xu C, et al. Behavioral deficits, abnormal corticosterone, and reduced prefrontal metabolites of adolescent rats subject to early life stress. Neurosci Lett. 2013;545:132–7. doi:10.1016/j.neulet.2013.04.035.
22. Nader N, Chrousos GP, Kino T. Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab TEM. 2010;21(5):277–86. doi:10.1016/j.tem.2009.12.011.
23. Kiessling S, Eichele G, Oster H. Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag. J Clin Invest. 2010;120(7):2600–9. doi:10.1172/JCI41192.
24. Le Minh N, Damiola F, Tronche F, Schutz G, Schibler U. Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators. EMBO J. 2001;20(24):7128–36. doi:10.1093/emboj/20.24.7128.
25. Kalsbeek A, van der Spek R, Lei J, Endert E, Buijs RM, Fliers E. Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Mol Cell Endocrinol. 2012;349(1):20–9. doi:10.1016/j.mce.2011.06.042.
26. Oster H, Damerow S, Kiessling S, Jakubcakova V, Abraham D, Tian J, et al. The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 2006;4(2):163–73. doi:10.1016/j.cmet.2006.07.002.
27. Charmandari E, Chrousos GP, Lambrou GI, Pavlaki A, Koide H, Ng SS, et al. Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One. 2011;6(9):e25612. doi:10.1371/journal.pone.0025612.
28. Leliavski A, Shostak A, Husse J, Oster H. Impaired glucocorticoid production and response to stress in Arntl-deficient male mice. Endocrinology. 2014;155(1):133–42. doi:10.1210/en.2013-1531.
29. Lamia KA, Papp SJ, Yu RT, Barish GD, Uhlenhaut NH, Jonker JW, et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature. 2011;480(7378):552–6. doi:10.1038/nature10700.
30. Dallmann R, Touma C, Palme R, Albrecht U, Steinlechner S. Impaired daily glucocorticoid rhythm in Per1 (Brd) mice. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2006;192(7):769–75. doi:10.1007/s00359-006-0114-9.
31. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ, et al. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 2009;19(12):2163–71. doi:10.1101/gr.097022.109.
32. Yan J, Wang H, Liu Y, Shao C. Analysis of gene regulatory networks in the mammalian circadian rhythm. PLoS Comput Biol. 2008;4(10):e1000193. doi:10.1371/journal.pcbi.1000193.
33. Boyson CO, Holly EN, Shimamoto A, Albrechet-Souza L, Weiner LA, Debold JF, et al. Social Stress and CRF-Dopamine Interactions in the VTA: Role in Long-Term Escalation of Cocaine Self-Administration. J Neurosci Off J Soc Neurosci. 2014;34(19):6659–67. doi:10.1523/JNEUROSCI.3942-13.2014.
34. Parnaudeau S, Dongelmans ML, Turiault M, Ambroggi F, Delbes AS, Cansell C, et al. Glucocorticoid receptor gene inactivation in dopamine-innervated areas selectively decreases behavioral responses to amphetamine. Front Behav Neurosci. 2014;8:35. doi:10.3389/fnbeh.2014.00035.
35. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med. 2005;11(1):35–42. doi:10.1038/nm1163.
36. Holubova K, Nekovarova T, Pistovcakova J, Sulcova A, Stuchlik A, Vales K. Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models. Front Behav Neurosci. 2014;8:130. doi:10.3389/fnbeh.2014.00130.
37. Castaneda TR, de Prado BM, Prieto D, Mora F. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res. 2004;36(3):177–85.
38. Wagner S, Castel M, Gainer H, Yarom Y. GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity. Nature. 1997;387(6633):598–603. doi:10.1038/42468.
39. Liu C, Reppert SM. GABA synchronizes clock cells within the suprachiasmatic circadian clock. Neuron. 2000;25(1):123–8.
40. Di S, Maxson MM, Franco A, Tasker JG. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J Neurosci Off J Soc Neurosci. 2009;29(2):393–401. doi:10.1523/JNEUROSCI.4546-08.2009.
41. Kitayama N, Vaccarino V, Kutner M, Weiss P, Bremner JD. Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J Affect Disord. 2005;88(1):79–86. doi:10.1016/j.jad.2005.05.014.
42. Loh DH, Navarro J, Hagopian A, Wang LM, Deboer T, Colwell CS. Rapid changes in the light/dark cycle disrupt memory of conditioned fear in mice. PloS one. 2010;5(9):e12546. doi:10.1371/journal.pone.0012546.
43. Koenen KC, Saxe G, Purcell S, Smoller JW, Bartholomew D, Miller A, et al. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry. 2005;10(12):1058–9. doi:10.1038/sj.mp.4001727.
44. Roy A, Gorodetsky E, Yuan Q, Goldman D, Enoch MA. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2010;35(8):1674–83. doi:10.1038/npp.2009.236.
45. Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S, et al. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci. 2008;28(2):389–98. doi:10.1111/j.1460-9568.2008.06332.x.
46. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36(12):1319–25. doi:10.1038/ng1479.
47. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA J Am Med Assoc. 2008;299(11):1291–305. doi:10.1001/jama.299.11.1291.
48. Colwell CS, Michel S, Itri J, Rodriguez W, Tam J, Lelievre V, et al. Selective deficits in the circadian light response in mice lacking PACAP. Am J Physiol Regul Integr Comp Physiol. 2004;287(5):R1194–201. doi:10.1152/ajpregu.00268.2004.
49. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. 2011;470(7335):492–7. doi:10.1038/nature09856.
50. Almli LM, Mercer KB, Kerley K, Feng H, Bradley B, Conneely KN, et al. ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2013;162B(3):262–72. doi:10.1002/ajmg.b.32145.
51. Stevens JS, Almli LM, Fani N, Gutman DA, Bradley B, Norrholm SD, et al. PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus. Proc Natl Acad Sci U S A. 2014;111(8):3158–63. doi:10.1073/pnas.1318954111.
52. Logue MW, Baldwin C, Guffanti G, Melista E, Wolf EJ, Reardon AF, et al. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry. 2013;18(8):937–42. doi:10.1038/mp.2012.113. The first genome wide analysis of PTSD, revealed variant RORA as the strongest association.
53. Amstadter AB, Sumner JA, Acierno R, Ruggiero KJ, Koenen KC, Kilpatrick DG, et al. Support for association of RORA variant and post traumatic stress symptoms in a population-based study of hurricane exposed adults. Mol Psychiatry. 2013;18(11):1148–9. doi:10.1038/mp.2012.189.
54. Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD, et al. A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry. 2010;67(2):133–8. doi:10.1016/j.biopsych.2009.08.029.
55. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry. 2009;14(8):755–63. doi:10.1038/mp.2009.43.
56. Terracciano A, Tanaka T, Sutin AR, Sanna S, Deiana B, Lai S, et al. Genome-wide association scan of trait depression. Biol Psychiatry. 2010;68(9):811–7. doi:10.1016/j.biopsych.2010.06.030.
57. Nguyen A, Rauch TA, Pfeifer GP, Hu VW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J Off Publ Fed Am Soc Exp Biol. 2010;24(8):3036–51. doi:10.1096/fj.10-154484.
58. McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK. A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS One. 2012;7(2):e32091. doi:10.1371/journal.pone.0032091.
59. Antshel KM, Kaul P, Biederman J, Spencer TJ, Hier BO, Hendricks K, et al. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission. J Clin Psychiatry. 2013;74(3):e197–204. doi:10.4088/JCP.12m07698.
60. Peyre H, Hoertel N, Cortese S, Acquaviva E, De Maricourt P, Limosin F, et al. Attention-deficit/hyperactivity disorder symptom expression: a comparison of individual age at onset using item response theory. J Clin Psychiatry. 2014;75(4):386–92. doi:10.4088/JCP.13m08638.
61. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–65. doi:10.1017/S003329170500471X.
62. Arns M, van der Heijden KB, Arnold LE, Kenemans JL. Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry. 2013;74(8):585–90. doi:10.1016/j.biopsych.2013.02.010.
63. Kissling C, Retz W, Wiemann S, Coogan AN, Clement RM, Hunnerkopf R, et al. A polymorphism at the 3'-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2008;147(3):333–8. doi:10.1002/ajmg.b.30602.
64. Xu X, Breen G, Chen CK, Huang YS, Wu YY, Asherson P. Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder. Behav Brain Funct BBF. 2010;6:48. doi:10.1186/1744-9081-6-48.
65. Jeong SH, Yu JC, Lee CH, Choi KS, Choi JE, Kim SH, et al. Human CLOCK gene-associated attention deficit hyperactivity disorder-related features in healthy adults: quantitative association study using Wender Utah Rating Scale. Eur Arch Psychiatry Clin Neurosci. 2014;264(1):71–81. doi:10.1007/s00406-013-0443-y.
66. Baird AL, Coogan AN, Siddiqui A, Donev RM, Thome J. Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels. Mol Psychiatry. 2012;17(10):988–95. doi:10.1038/mp.2011.149. The first molecular characterization of clock gene expression in human patients with ADHD.
67. Zhou M, Rebholz H, Brocia C, Warner-Schmidt JL, Fienberg AA, Nairn AC, et al. Forebrain overexpression of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD. Proc Natl Acad Sci U S A. 2010;107(9):4401–6. doi:10.1073/pnas.0915173107.
68. O'Keeffe SM, Thome J, Coogan AN. The noradrenaline reuptake inhibitor atomoxetine phase-shifts the circadian clock in mice. Neuroscience. 2012;201:219–30. doi:10.1016/j.neuroscience.2011.11.002.
69. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010;167(3):261–80. doi:10.1176/appi.ajp.2009.09030361.
70. Susser E, St Clair D, He L. Latent effects of prenatal malnutrition on adult health: the example of schizophrenia. Ann N Y Acad Sci. 2008;1136:185–92. doi:10.1196/annals.1425.024.
71. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry. 2005;162(1):12–24. doi:10.1176/appi.ajp.162.1.12.
72. Byrne EM, Heath AC, Madden PA, Pergadia ML, Hickie IB, Montgomery GW, et al. Testing the role of circadian genes in conferring risk for psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2014;165B(3):254–60. doi:10.1002/ajmg.b.32230.
73. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014. doi:10.1038/nature13595. advance online publication.
74. Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E, et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry. 2013;18(12):1302–7. doi:10.1038/mp.2012.142.
75. Byrne EM, Gehrman PR, Medland SE, Nyholt DR, Heath AC, Madden PA, et al. A genome-wide association study of sleep habits and insomnia. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2013;162B(5):439–51. doi:10.1002/ajmg.b.32168.
76. Colwell CS. Circadian modulation of calcium levels in cells in the suprachiasmatic nucleus. Eur J Neurosci. 2000;12(2):571–6.
77. Lundkvist GB, Kwak Y, Davis EK, Tei H, Block GD. A calcium flux is required for circadian rhythm generation in mammalian pacemaker neurons. J Neurosci Off J Soc Neurosci. 2005;25(33):7682–6. doi:10.1523/JNEUROSCI.2211-05.2005.
78. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148(6):1223–41. doi:10.1016/j.cell.2012.02.039.
79. Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature. 2011;471(7339):499–503. doi:10.1038/nature09884. Clock gene variant with very high effect size implicated in schizophrenia.
80. Evans JA, Leise TL, Castanon-Cervantes O, Davidson AJ. Dynamic interactions mediated by nonredundant signaling mechanisms couple circadian clock neurons. Neuron. 2013;80(4):973–83. doi:10.1016/j.neuron.2013.08.022.
81. Harmar AJ. An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei. J Neuroendocrinol. 2003;15(4):335–8.
82. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552–62.
83. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60(5):497–502. doi:10.1001/archpsyc.60.5.497.
84. McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther. 2007;114(2):222–32. doi:10.1016/j.pharmthera.2007.02.003.
85. Boyce P, Barriball E. Circadian rhythms and depression. Aust Fam Physician. 2010;39(5):307–10.
86. Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):722–9. doi:10.1016/j.pnpbp.2010.04.011.
87. Daban C, Vieta E, Mackin P, Young AH. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin N Am. 2005;28(2):469–80. doi:10.1016/j.psc.2005.01.005.
88. Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak-Rieder N, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology. 2011;64(3):152–62. doi:10.1159/000328950.
89. Lewy AJ, Rough JN, Songer JB, Mishra N, Yuhas K, Emens JS. The phase shift hypothesis for the circadian component of winter depression. Dialogues Clin Neurosci. 2007;9(3):291–300.
90. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry. 2009;66(3):298–301. doi:10.1016/j.biopsych.2009.02.018.
91. Di Giannantonio M, Martinotti G. Anhedonia and major depression: the role of agomelatine. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2012;22 Suppl 3:S505–10. doi:10.1016/j.euroneuro.2012.07.004.
92. Fornaro M, McCarthy MJ, De Berardis D, De Pasquale C, Tabaton M, Martino M, et al. Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study. Neuropsychiatr Dis Treat. 2013;9:243–51. doi:10.2147/NDT.S41557.
93. Benedetti F, Serretti A, Colombo C, Barbini B, Lorenzi C, Campori E, et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2003;123B(1):23–6. doi:10.1002/ajmg.b.20038.
94. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2010;35(6):1279–89. doi:10.1038/npp.2009.230.
95. Utge SJ, Soronen P, Loukola A, Kronholm E, Ollila HM, Pirkola S, et al. Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance. PLoS One. 2010;5(2):e9259. doi:10.1371/journal.pone.0009259.
96. Li JZ, Bunney BG, Meng F, Hagenauer MH, Walsh DM, Vawter MP, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci USA. 2013;110(24):9950–5. doi:10.1073/pnas.1305814110. Human brain samples of subjects with depression unveil disturbed circadian rhythms in mood-regulating brain areas.
97. McCarthy MJ, Wei H, Marnoy Z, Darvish RM, McPhie DL, Cohen BM, et al. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl Psychiatry. 2013;3:e318. doi:10.1038/tp.2013.90.
98. Naylor E, Bergmann BM, Krauski K, Zee PC, Takahashi JS, Vitaterna MH, et al. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci Off J Soc Neurosci. 2000;20(21):8138–43.
99. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A. 2007;104(15):6406–11. doi:10.1073/pnas.0609625104.
100. Ozburn AR, Larson EB, Self DW, McClung CA. Cocaine self-administration behaviors in ClockDelta19 mice. Psychopharmacology. 2012;223(2):169–77. doi:10.1007/s00213-012-2704-2.
101. Abarca C, Albrecht U, Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc Natl Acad Sci U S A. 2002;99(13):9026–30. doi:10.1073/pnas.142039099.
102. Spencer S, Falcon E, Kumar J, Krishnan V, Mukherjee S, Birnbaum SG, et al. Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. Eur J Neurosci. 2013;37(2):242–50. doi:10.1111/ejn.12010. Reduced PER1/2 levels in the nucleus accumbens are correlated with anxiety-like behavior in mice.
103. Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J, et al. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2008;147B(2):134–66. doi:10.1002/ajmg.b.30707.
104. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA J Am Med Assoc. 1984;252(14):1905–7.
105. Mayfield RD, Harris RA, Schuckit MA. Genetic factors influencing alcohol dependence. Br J Pharmacol. 2008;154(2):275–87. doi:10.1038/bjp.2008.88.
106. Drummond SP, Gillin JC, Smith TL, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res. 1998;22(8):1796–802.
107. Wong MM, Brower KJ, Nigg JT, Zucker RA. Childhood sleep problems, response inhibition, and alcohol and drug outcomes in adolescence and young adulthood. Alcohol Clin Exp Res. 2010;34(6):1033–44. doi:10.1111/j.1530-0277.2010.01178.x.
108. Wittmann M, Paulus M, Roenneberg T. Decreased psychological well-being in late 'chronotypes' is mediated by smoking and alcohol consumption. Subst Use Misuse. 2010;45(1–2):15–30. doi:10.3109/10826080903498952.
109. Adan A. Chronotype and personality factors in the daily consumption of alcohol and psychostimulants. Addiction. 1994;89(4):455–62.
110. Gianoulakis C, Dai X, Thavundayil J, Brown T. Levels and circadian rhythmicity of plasma ACTH, cortisol, and beta-endorphin as a function of family history of alcoholism. Psychopharmacology. 2005;181(3):437–44. doi:10.1007/s00213-005-0129-x.
111. Garcia-Burgos D, Gonzalez F, Manrique T, Gallo M. Patterns of ethanol intake in preadolescent, adolescent, and adult Wistar rats under acquisition, maintenance, and relapse-like conditions. Alcohol Clin Exp Res. 2009;33(4):722–8. doi:10.1111/j.1530-0277.2008.00889.x.
112. Perreau-Lenz S, Zghoul T, de Fonseca FR, Spanagel R, Bilbao A. Circadian regulation of central ethanol sensitivity by the mPer2 gene. Addict Biol. 2009;14(3):253–9. doi:10.1111/j.1369-1600.2009.00165.x.
113. Dong L, Bilbao A, Laucht M, Henriksson R, Yakovleva T, Ridinger M, et al. Effects of the circadian rhythm gene period 1 (per1) on psychosocial stress-induced alcohol drinking. Am J Psychiatry. 2011;168(10):1090–8. doi:10.1176/appi.ajp.2011.10111579.
114. Wang X, Mozhui K, Li Z, Mulligan MK, Ingels JF, Zhou X, et al. A promoter polymorphism in the Per3 gene is associated with alcohol and stress response. Transl Psychiatry. 2012;2:e73. doi:10.1038/tp.2011.71.
115. Hofstetter JR, Grahame NJ, Mayeda AR. Circadian activity rhythms in high-alcohol-preferring and low-alcohol-preferring mice. Alcohol. 2003;30(1):81–5.
116. Rosenwasser AM, Fecteau ME, Logan RW, Reed JD, Cotter SJ, Seggio JA. Circadian activity rhythms in selectively bred ethanol-preferring and nonpreferring rats. Alcohol. 2005;36(2):69–81. doi:10.1016/j.alcohol.2005.07.001.
117. Kovanen L, Saarikoski ST, Haukka J, Pirkola S, Aromaa A, Lonnqvist J, et al. Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. Alcohol Alcohol. 2010;45(4):303–11. doi:10.1093/alcalc/agq035.
118. Comasco E, Nordquist N, Gokturk C, Aslund C, Hallman J, Oreland L, et al. The clock gene PER2 and sleep problems: association with alcohol consumption among Swedish adolescents. Ups J Med Sci. 2010;115(1):41–8. doi:10.3109/03009731003597127.
119. Sjoholm LK, Kovanen L, Saarikoski ST, Schalling M, Lavebratt C, Partonen T. CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. J Circadian Rhythm. 2010;8:1. doi:10.1186/1740-3391-8-1.
120. McCarthy MJ, Fernandes M, Kranzler HR, Covault JM, Welsh DK. Circadian clock period inversely correlates with illness severity in cells from patients with alcohol use disorders. Alcohol Clin Exp Res. 2013;37(8):1304–10. doi:10.1111/acer.12106.
121. Perreau-Lenz S, Vengeliene V, Noori HR, Merlo-Pich EV, Corsi MA, Corti C, et al. Inhibition of the casein-kinase-1-epsilon/delta/ prevents relapse-like alcohol drinking. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2012;37(9):2121–31. doi:10.1038/npp.2012.62.
122. Arey R, McClung CA. An inhibitor of casein kinase 1 epsilon/delta partially normalizes the manic-like behaviors of the ClockDelta19 mouse. Behav Pharmacol. 2012;23(4):392–6. doi:10.1097/FBP.0b013e32835651fd.
123. Kojetin DJ, Burris TP. REV-ERB and ROR nuclear receptors as drug targets. Nat Rev Drug Discov. 2014;13(3):197–216. doi:10.1038/nrd4100.
124. Hirota T, Lee JW, St John PC, Sawa M, Iwaisako K, Noguchi T, et al. Identification of small molecule activators of cryptochrome. Science. 2012;337(6098):1094–7. doi:10.1126/science.1223710.
125. Jones KA, Hatori M, Mure LS, Bramley JR, Artymyshyn R, Hong SP, et al. Small-molecule antagonists of melanopsin-mediated phototransduction. Nat Chem Biol. 2013;9(10):630–5. doi:10.1038/nchembio.1333.